Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
. 2020 Apr 7:ciaa394. doi: 10.1093/cid/ciaa394

Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients

Sophie Perinel 1,2, Manon Launay 3, Élisabeth Botelho-Nevers 4, Éric Diconne 1, Aurore Louf-Durier 1, Raphaël Lachand 1, Martin Murgier 1, Dominique Page 1, Régine Vermesch 1, Guillaume Thierry 1, Xavier Delavenne 2,3,
PMCID: PMC7184449  PMID: 32255489

Abstract

Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.


Articles from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America are provided here courtesy of Oxford University Press

RESOURCES